MedPath

Illumina

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
10.6K
Market Cap
-
Website

CardioSeq: Impact of WGS in Individuals With CVD

Not Applicable
Active, not recruiting
Conditions
Cardiovascular Diseases
Interventions
Diagnostic Test: TruGenome Cardiovascular Disease test
First Posted Date
2022-12-19
Last Posted Date
2024-04-30
Lead Sponsor
Illumina, Inc.
Target Recruit Count
1500
Registration Number
NCT05656183
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Henry Ford Health System, Detroit, Michigan, United States

iKnow: A Prospective Study to Evaluate the Use of Multi-omics in Multi-System, Early Onset Disorders

Active, not recruiting
Conditions
Genetic Disease
First Posted Date
2021-09-20
Last Posted Date
2024-04-30
Lead Sponsor
Illumina, Inc.
Target Recruit Count
150
Registration Number
NCT05049967
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Clinic for Special Children, Strasburg, Pennsylvania, United States

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

Completed
Conditions
SARS-CoV-2
Interventions
Diagnostic Test: Diagnostic test for detection of SARS-CoV-2
First Posted Date
2020-09-23
Last Posted Date
2022-01-21
Lead Sponsor
Illumina, Inc.
Target Recruit Count
644
Registration Number
NCT04561102
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Rollins College Alfonds Sports Center, Winter Park, Florida, United States

Evaluation of the COVIDSeq Test in Saliva Specimens From COVID-19 Asymptomatic Illumina Personnel

Completed
Conditions
SARS-CoV-2
Interventions
Diagnostic Test: COVIDSeq Test
First Posted Date
2020-09-23
Last Posted Date
2022-01-21
Lead Sponsor
Illumina, Inc.
Target Recruit Count
763
Registration Number
NCT04561089
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Illumina Hayward, Hayward, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Illumina Laboratory Services, San Diego, California, United States

NeuroSeq: A Prospective Trial to Evaluate the Diagnostic Yield of Whole Genome Sequencing (WGS) in Adult Neurology

Completed
Conditions
Neurologic Abnormalities
Neurologic Disorder
Neurologic Deficits
Interventions
Other: clinical Whole Genome Sequencing
First Posted Date
2019-11-20
Last Posted Date
2024-05-01
Lead Sponsor
Illumina, Inc.
Target Recruit Count
160
Registration Number
NCT04170985
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univ. of Pennsylvania, Philadelphia, Pennsylvania, United States

A Study Collecting Blood Samples From Pregnant Women to Aid in the Development of a Noninvasive Prenatal Test

Completed
Conditions
Pregnancy
First Posted Date
2018-08-08
Last Posted Date
2020-01-14
Lead Sponsor
Illumina, Inc.
Target Recruit Count
2209
Registration Number
NCT03620110
Locations
๐Ÿ‡บ๐Ÿ‡ธ

United Women's Clinical Research-Greensboro, Greensboro, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

Unified Women's Clinical Research - Raleigh, Raleigh, North Carolina, United States

๐Ÿ‡บ๐Ÿ‡ธ

The Group for Women, Norfolk, Virginia, United States

and more 5 locations

Collection of Whole Blood Specimens in Pregnant Women

Completed
Conditions
Pregnancy Related
First Posted Date
2018-07-18
Last Posted Date
2022-05-05
Lead Sponsor
Illumina, Inc.
Target Recruit Count
3000
Registration Number
NCT03590678
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Mater Misericordiae Limited, South Brisbane, Queensland, Australia

๐Ÿ‡น๐Ÿ‡ญ

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand

๐Ÿ‡ต๐Ÿ‡ฑ

FERTINA Sp. z o.o. SPร“ลKA KOMANDYTOWA, Warszawa, Poland

and more 13 locations

NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants

Not Applicable
Completed
Conditions
Rare Diseases
Interventions
Other: clinical whole genome sequencing (cWGS)
First Posted Date
2017-09-25
Last Posted Date
2020-11-18
Lead Sponsor
Illumina, Inc.
Target Recruit Count
355
Registration Number
NCT03290469
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Rady's/Children's Hospital of Orange County, Orange, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Children's Hospital of Philadelpia, Philadelphia, Pennsylvania, United States

๐Ÿ‡บ๐Ÿ‡ธ

Washington University in St. Louis School of Medicine & St. Louis Children's Hospital, Saint Louis, Missouri, United States

and more 2 locations

Development of a Next Generation Sequencing (NGS) -Based Assay to Detect Preeclampsia Molecular Markers

Completed
Conditions
Preeclampsia
First Posted Date
2016-06-21
Last Posted Date
2022-04-29
Lead Sponsor
Illumina, Inc.
Target Recruit Count
242
Registration Number
NCT02808494
Locations
๐Ÿ‡บ๐Ÿ‡ธ

The University of Texas Medical Branch, Galveston, Texas, United States

๐Ÿ‡บ๐Ÿ‡ธ

Rutgers University, Piscataway, New Jersey, United States

๐Ÿ‡บ๐Ÿ‡ธ

Virtua Materna-Fetal Medicine Specialists, Sewell, New Jersey, United States

and more 7 locations

Single Embryo TrAnsfeR of Euploid Embryo

Not Applicable
Completed
Conditions
Aneuploidy
Infertility
Interventions
Other: Preimplantation Genetic Screening by NGS
First Posted Date
2014-10-20
Last Posted Date
2020-05-13
Lead Sponsor
Illumina, Inc.
Target Recruit Count
661
Registration Number
NCT02268786
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Acacio Fertility Clinic, Laguna Niguel, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

HRC Fertility, Encino, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Reproductive Science Center of San Francisco Bay Area, San Ramon, California, United States

and more 34 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath